Impact of PCA3 assay on the number of repeat prostate biopsies

The latest case study in urology, which is applied systematically, shows that the PCA3 Assay can reduce the number of repeat biopsies while maintaining the sensitivity to detect high-grade prostate cancer.

When PCA3 Score is taken into account, the repeat biopsy was avoidable in 64% of men in the case.

The conclusion of the study shows, that PCA3 Score should be taken into account, because it offers the highest reduction in repeat biopsy while maintaining the sensitivity to detect high-grade prostate cancer.